Hepatitis B and C network meeting
The fifth meeting of the Hepatitis B and C Network brings together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
The objectives of the meeting are:
- To review the different systems for understanding the hepatitis B and C epidemics across the European Union (EU) and European Economic Area (EEA) and monitoring progress towards elimination;
- To discuss hepatitis testing in Europe and identify opportunities for scaling up testing and reducing the undiagnosed fraction;
- To identify future priorities for hepatitis elimination and discuss ECDC's supporting role.
Discussions include an overview of European priorities for viral hepatitis, integrated testing, how to address the data gaps and a progress report on the global hepatitis elimination.
Representatives from the World Health Organization, the Coalition for Global Hepatitis Elimination and the World Hepatitis Alliance are among some of the invited stakeholders.
The European Network for hepatitis B and C surveillance was established by the European Centre for Disease Prevention and Control in 2010. It consists of nominated contact points from EU/EEA. A Coordination Committee was also set up from this network to closely oversee the implementation of enhanced surveillance.
Hepatitis B is a liver disease that results from infection with the hepatitis B virus (HBV) and is spread through contact with infected body fluids or blood products.Read more
Hepatitis C is a liver disease caused by infection with the hepatitis C virus (HCV). HCV can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness that lasts only a few weeks to a serious, lifelong illness resulting in cirrhosis and liver cancer.Read more